An oral and selective CDK7 inhibitor demonstrates substantial anti-tumor effect in breast and ovarian cancer models

被引：0
|
作者：
Hu, S. [1 ]
Marineau, J. [1 ]
Bradley, M. [1 ]
Hamman, K. [1 ]
Alnemy, S. [1 ]
Smith, D. [1 ]
Carulli, J. [1 ]
Chuaqui, C. [1 ]
机构：
[1] Syros Pharmaceut Inc, Drug Discovery, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
96 (PB-047
引用
收藏
页码：E39 / E40
页数：2
相关论文
共 50 条
  • [1] The development of a selective CDK7 inhibitor with anti-tumor activity
    Coombes, Raoul
    Cheiper
    Jogalekar, Ashutosh S.
    Brackow, Jan
    Ali, Simak
    Heathcote, Dean
    Kroll, Sebastian
    Bodo, S.
    Siwicka, Aleksandra
    Periyasamy, Manikandan
    Tolhurst, Robert
    Kanneganti, Seshu
    Snyder, James
    Liotta, Dennis
    Aboagye, Eric
    Barrett, Anthony
    CANCER RESEARCH, 2009, 69
  • [2] SY-5609, an orally available selective CDK7 inhibitor demonstrates broad anti-tumor activity in vivo
    Hu, Shanhu
    Marineau, Jason
    Hamman, Kristin
    Bradley, Michael
    Savinainen, Anneli
    Alnemy, Sydney
    Rajagopal, Nisha
    Orlando, David
    Chuaqui, Claudio
    Olson, Eric
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Q901; a highly selective covalent cdk7 inhibitor inducing substantial anti-tumor effect in a broad spectrum of solid tumor lineages
    Yu, Donghoon
    Jeon, Yeejin
    Lee, Seung-Joo
    Kim, Jaeseung
    Nam, Kiyean
    CANCER RESEARCH, 2022, 82 (12)
  • [4] An oral and selective CDK12 inhibitor demonstrates robust anti-tumor activity
    Hu, Shanhu
    Moebius, David
    Dworakowski, Wojciech
    Cooper, Elliott
    LaPlaca, Derek
    Alnemy, Sydney
    Perera, Phone
    Marineau, Jason
    Chuaqui, Claudio
    Carulli, John P.
    Olson, Eric
    CANCER RESEARCH, 2022, 82 (12)
  • [5] A selective, potent, and orally bioavailable CDK7 inhibitor demonstrates superior anti-cancer activity in colorectal cancer models
    Park, Heuijoon
    Seo, Kyoungwan
    Yu, Jihyun
    Kim, Jieun
    Joo, Min Sung
    Kim, Sungeun
    Lee, Joonhyung
    Lee, Jeonghyeon
    Kim, Eun-Jung
    Nam, Joonwoo
    Han, Wooseok
    CANCER RESEARCH, 2024, 84 (07)
  • [6] Potent anti-tumor activity of AUR102, a selective covalent inhibitor of CDK7
    Satyam, L. K.
    Poddutoori, R.
    Thiyagarajan, S.
    Mukherjee, S.
    Kaza, L. N.
    Charamanna, K.
    Marappan, S.
    Samiulla, D.
    Tiwari, N. K.
    Devaraja, T.
    Aravind, A.
    Dhudashiya, A. A.
    Booher, R.
    Daginakatte, G.
    Antony, T.
    Chelur, S.
    Nellore, K.
    Giri, S.
    Ramachandra, M.
    Samajdar, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S47 - S47
  • [7] Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma
    Gao, Yang
    Volegova, Marina
    Nasholm, Nicole
    Das, Sanjukta
    Kwiatkowski, Nicholas
    Abraham, Brian J.
    Zhang, Tinghu
    Gray, Nathanael S.
    Gustafson, Clay
    Krajewska, Malgorzata
    George, Rani E.
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [8] In vivo anti-tumor efficacy of UD-017, a novel highly selective & orally available CDK7 inhibitor, in colorectal cancer cells xenograft models
    Aga, Yasuhiro
    Ogi, Sayaka
    Tokunaga, Yasunori
    Ogawa, Ayumi
    Onuma, Kazuhiro
    Matsushita, Takashi
    Sunamoto, Hidetoshi
    Hasegawa, Tom
    Ushiyama, Shigeru
    CANCER RESEARCH, 2017, 77
  • [9] ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancer
    Ali, Simak
    Patel, Hetal
    Periyasamy, Manikandan
    Bondke, Alexander
    Slafer, Brian W.
    Ottaviani, Silvia
    Harrod, Alison
    Buluwela, Laki
    Fuchter, Matthew J.
    Barrett, Anthony G. M.
    Coombes, R. Charles
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 195 - 195
  • [10] SY-1365, a potent and selective CDK7 inhibitor, exhibits promising anti-tumor activity in multiple preclinical models of aggressive solid tumors
    Hu, Shanhu
    Ke, Nan
    Ren, Yixuan
    Miljovska, Sofija
    Rajagopal, Nisha
    McKeown, Michael
    Orlando, David
    Sprott, Kevin
    Choi, Yoon J.
    Olson, Eric
    Fritz, Christian C.
    CANCER RESEARCH, 2017, 77
12345